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Abstract
Reelin (RELN), which is a glycoprotein secreted by Cajal-Retzius cells of the developing cerebral cortex, plays an important
role in neuronal migration, but its role in cell migration and cancer metastasis is largely unclear. Here, we showed that cell
motility was significantly increased in KYSE-510 cells by TGF-b1 treatment. Moreover, TGF-b1 decreased RELN mRNA
expression and overexpression of Reelin at least partly reversed TGF-b1-induced cell migration in KYSE-30 cells.
Furthermore, this negative regulation of Reelin expression by TGF-b1 was through Snail, one transcription factor which was
induced by TGF-b1 in KYSE-510 cells. RELN promoter activity was reduced in parallel with the induction of Snail after TGF-b1
treatment and Snail suppressed both RELN promoter activity and expression through binding to E-box sequences in the
RELN promoter region in ESCC cells. Knockdown of RELN induced cell migration in KYSE-510 cells, together with the
increase of mesenchymal markers expression. Taken together, Reelin is an essential negative regulator in the TGF-b1-
induced cell migration process, and is suppressed by TGF-b pathway at the transcriptional level through Snail regulation.
Therefore, the correlation of Reelin and TGF-b pathway was critical in cancer metastasis, and Reelin could be one potential
anti-metastasis target in future clinical practice.
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Introduction
Reelin was known as a large glycoprotein secreted from Cajal-
Retzius cells of developing cerebral cortex, and acts as a critical
regulator of neuronal migration and layer formation during brain
development [1,2]. Reelin binds to Apolipoprotein E Receptor 2
(ApoER2) and very low-density lipoprotein receptor (VLDLR) [3],
and thereby induces phosphorylation of an intracellular adaptor
protein, Disabled-1 (Dab1) [4]. The physiological function of
Reelin was intensively studied in brain, however, recently, RELN
was found to be epigenetically silenced in different cancers
including pancreatic [5], gastric [6] and breast cancer [7].
Moreover, the decreased expression of RELN was associated with
increased migratory ability, reduced survival and poor prognosis,
reduced expression of Reelin is associated with high recurrence
rate of hepatocellular carcinoma [8]. In contrast, strong Reelin
expression was found to be correlated with high-grade prostate
cancer [9].
Esophageal cancer is the sixth leading cause of cancer death
worldwide and, interestingly, also the least studied type of tumor
[10]. There is an exceedingly high incidence of esophageal
squamous cell carcinoma (ESCC) in Asian countries, especially in
north and central China [11]. Although 90% of cancer deaths are
caused by metastasis [12], the mechanism of cancer metastasis
remains poorly defined, and understanding this process will
provide great promise for cancer therapy. Epithelial-mesenchy-
mal transition (EMT) is thought to be a crucial step of metastasis
[13]. During embryo development, organogenesis and wound
repair, EMT is tightly controlled temporally and spatially, but
when EMT is dysregulated, it will cause fibrosis and invasion and
metastasis of carcinoma [14,15,16]. During EMT, the epithelial
cells lose the polarity and become more migratory, fibroblast-like
cells with concomitant loss of expression of epithelial markers,
such as cytokeratins, E-cadherin, and desmoplakin [17]. EMT
can be induced by many cytokines, and transforming growth
factor-b (TGF-b) was found to be critical for EMT induction. In
response to TGF-b1, the Smad-dependent signaling pathway
cooperates with other Smad-independent pathways to regulate
target genes, including Snail family, ZEB family, Twist, etc
[18,19,20]. However, the role of TGF-b in esophageal carcino-
genesis and its signaling pathway in EMT process are not yet
understood.
Although it is known that Reelin expression can be regulated in
many important processes, very little is known with respect to how
the expression of Reelin is regulated in esophageal epithelial cells
and its role in ESCC metastasis and TGF-b signaling. In this
study, we demonstrated that Reelin over-expression suppressed
TGF-b1-induced motility of KYSE-30 cells, and its expression can
be regulated by Snail. Our results provide the first evidence that
Reelin was involved in TGF-b signal pathway, which contributes
to cancer metastasis and could be useful for anti-cancer strategies.
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TGF-b1 Induces Cell Morphologic Changes and Migration
in Esophageal Carcinoma Cell Lines
Since the role of TGF-b in esophageal carcinogenesis is not yet
understood, we investigated whether TGF-b1 treatment induced
ESCC cells to mesenchymal transition and further elucidated the
underlying mechanism responsible for the process. KYSE-30 and
KYSE-510 cells were treated with TGF-b1 and morphologic
phenotypes were examined under an inverted phase-contrast
microscope. As shown in Figure S1A and Figure 1A, TGF-b
significantly induced KYSE-30 and KYSE-510 cell spreading after
24 hours treatment. Transwell assays proved the motility of KYSE-
510 cells was increased (Figure 1B), excluding the possibility of cell
number increase (Figure 1C). TGF-b1 suppressed E-cadherin
expression and increased N-cadherin expression (Figure 1D). Since
theprotein levelof Vimentinand Fibronectin was lowinKYSE-510
cells, we could not detect the expression by Western blot; therefore
the mRNA expression level was determined in this study. As shown
in Figure 1E, TGF-b1 significantly increased the mRNA expression
levelsofmesenchymalmarkers:VimentinandFibronectinat24and
48 hours after treatment. Although TGF-b1 significantly sup-
pressed KYSE-30 cells growth (Figure S1B), the mRNA expression
of Vimentin was also increased (Figure S1C).
TGF-b1 Suppressed RELN Expression and TGF-b1-
Induced Migration Was Suppressed by Reelin
Overexpression
Reelin was reported to be important in neural development and
cancer metastasis, thus we speculated that Reelin might be
involved in TGF-b1-induced cell migration. We first detected the
mRNA expression of RELN in ESCC cell lines. As shown in
Figure 2A, RELN mRNA expression was low in most of ESCC
cell lines except for KYSE-410 and KYSE-510 cells. Furthermore,
immunofluorescence showed that Reelin was mostly localized in
cytoplasm in KYSE-510 cells (Figure 2B). Importantly, we found
that RELN mRNA level was significantly decreased after 5 ng/ml
TGF-b1 treatment in KYSE30 and KYSE510 cells (Figure S1D
and Figure 2C). In contrast, RELN mRNA expression is relatively
low in KYSE-30 cells, so we overexpressed reelin in this cell line to
test whether Reelin plays a functional role in TGF-b1-induced cell
migration, we transiently transfected reelin expression vector
(pCrl) followed by TGF-b1 treatment in KYSE-30 cells
(Figure 2D), and found that Reelin overexpression significantly
abolished TGF-b1-induced cell migration, as shown by Transwell
assay (Figure 2E). These results suggested that Reelin is critical in
blocking the TGF-b1-induced cell migration.
TGF-b1 Transcriptional Regulated RELN Expression in
KYSE-510 Cells
To investigate whether TGF-b1 suppressed RELN expression
at transcriptional level, we constructed a luciferase reporter gene
vector pGL3-RELN carrying a core promoter of human RELN
extending from 2514 bp to +76 bp based on a previous report
[21] and transfected into KYSE-30 and KYSE-510 cells followed
by TGF-b1 treatment for 48 hours, and found that the luciferase
activity of RELN promoter was reduced comparing with control
(Figure 3A). To further evaluate whether TGF-b1 has the effect on
RELN mRNA stability, KYSE-510 cells were treated with TGF-
b1 for 1 hour prior to the addition of actinomycin D (ActD), and
quantitative RT-PCR analysis was performed. RELN mRNA
stability with or without TGF-b1 treatment was not different and
the half-life of RELN mRNA is ,16 hours (Figure 3B).
Transcriptional Regulation of RELN by Snail
It is well known that Snail plays important roles in TGF-b1
induced EMT process, and its expression was increased after
TGF-b1 treatment in many cancer cell lines [22,23,24]. After
TGF-b1 treatment, Snail expression was increased (Figure 4A) and
RELN expression was decreased (Figure 4B) in a time-dependent
manner in KYSE-510 cells. To assess regulation of Snail on RELN
expression, Snail overexpression construct pcDEF-Snail was
transfected into KYSE-30 and KYSE-510 cells, mRNA of RELN
was significantly decreased in KYSE-30 and KYSE-510 cells
(Figure 4C). Furthermore, co-transfection of pcDEF-Snail and the
RELN promoter region (2514/+76) led to a dose-dependent
decrease in luciferase activity (Figure 4D), indicating that Snail has
a repressive effect on RELN promoter.
Because Snail binds to specific sequences that contain a central
core sequence of 59-CACCTG-39 in the promoter of E-cadherin
gene, which was termed as E-box [25,26] and subsequently
represses the expression of E-cadherin, thus we speculated that
there might be some Snail binding sites in the RELN promoter
region. Fortunately, 2 specific sequences have been identified in
RELN promoter region which exactly matched E-box sequence,
located from 2466 to 2460 bp (59-CAGCTG-39) and 2206 to
2201 bp(59-CACGTG-39)relativetotheRNAstartsite(Figure4E,
left).Wesubsequentlyperformed aChIPassaytotestthishypothesis,
and found that Snail binds to the region extending from 2514 to
285 bp of RELN promoter very weakly; however, very interest-
ingly, Snail could strongly bind to the same sequences of RELN
promoter region after TGF-b1 treatment (Figure 4E, right).
RELN knockdown endowed KYSE-510 cells with stronger
motility
To characterize the physiological function of RELN, we
performed transient knockdown experiments using 2 pairs of
siRNAs (siRNA-2 and 5) targeting RELN in KYSE-510 cells. The
results demonstrated that RELN knockdown induced a marked
increase in cell migration (Figure 5A&B). We then constructed
specific RELN shRNA vectors and obtained RELN shRNA stable
clones (Figure 5C). Consistent with the transient transfection,
stable knockdown of RELN also increased cell motility (Figure 5D).
Meanwhile, the mRNA levels of some mesenchymal markers
Vimentin, Fibronectin and N-cadherin dramatically increased in
the RELN shRNA stable clone, whereas the epithelial marker E-
cadherin remained unchanged (Figure 5E). These data clearly
demonstrated that RELN functions as a cell migration suppressor.
RELN Expression in Esophageal Carcinoma Tissues
We subsequently detected RELN mRNA expression in 40 pairs
of human ESCC tissues by RT-qPCR (Figure 6), and the term
2DCt was used to describe the expression level of RELN. We
explored the relationship between the expression level of RELN in
ESCC tissues and various clinicopathological parameters (Table 1).
The median expression of RELN was 213.5 in the 21 cases with
advanced stage (stage III and IV) disease, whereas the median
expression was 212.2 in the 19 cases with early-stage (stage I and
II) disease. However, no significant difference was observed
between the 20 cases of ESCC with lymph node metastasis, the
median expression of RELN was 212.6, and the other 20 non-
metastasis ESCC cases, the median expression was 213.2.
(p=0.3803, Table 2).
Discussion
Reelin was necessary for migration of neuron from their site of
origin to their final destination and was expressed in embryonic
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physiological and pathological processes including embryonic
development, wound repair, and tumor metastasis [29,30]. In this
study, we demonstrated that Reelin probably functions as a cell
migration-related gene. We first found that Reelin was involved in
TGF-b1-stimulated migration. Downregulation of Reelin expres-
sion was detected in the KYSE-510 cells after TGF-b1 treatment.
Moreover, knockdown of RELN in the same cell line led to
dramatic increase in the expressions of several mesenchymal
markers including vimentin, fibronectin and N-cadherin, suggest-
ing that loss of RELN could endow cells with some mesenchymal
traits and stronger mobility (Figure 5). Considering the constant
expression of E-cadherin in those cells, the knockdown of RELN
in KYSE-510 cells was likely to go through a partial EMT
transition, which is proposed to assist migration and invasion [31].
Epithelial cells can migrate during development not only by
complete EMT, but also through collective migration where
epithelial cells physically and functionally connected as a group
[32,33,34]. One of the similarities between EMT and collective
migration was the acquisition of an invasive and motile phenotype;
however E-cadherin expression was decreased in EMT and
remained unchanged in collective migration. In this study,
Figure 1. TGF-b1 induced cell morphologic changes and migration in KYSE-510 cells. Cells were treated with 5 ng/ml TGF-b1 for indicated
time. A: After treatment of TGF-b1 or control, morphologic phenotypes and KYSE-510 cells were examined under an inverted phase-contrast
microscope. Scale bars,2 0mm. B: Transwell assay showing TGF-b1-induced cell migration in KYSE-510 cells. Cells were stained with crystal violet (top).
The bar graph shows the relative number of migrated cells from three independent experiments (mean6SE, bottom). *, p,0.05. C: Measurement of
cell viability and proliferation KYSE-510 after TGF-b1 treatment by MTT assay. D: Western blot for N-cadherin and E-cadherin using whole cell extract
at 48 hours after TGF-b1 treatment in KYSE510 cells. b-actin served as the loading control. E: RT-qPCR analysis showing the mRNA expression levels of
some EMT markers in KYSE-510 cells with or without TGF-b1 treatment for indicated time. Data represent the mean 6 SD of triplicate experiments.
doi:10.1371/journal.pone.0031802.g001
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maintaining E-cadherin expression which functions in cell-cell
adhesion, but the mechanism of cell-cell adhesion in the process of
ESCC cell migration is still not clear and needs to be further
investigated.
Notably, our findings reveal an unknown link between Snail,
which triggers EMT process and favors tumor progression [35,36],
and RELN gene. Snail is a zinc finger transcriptional repressor
which has a highly conserved C-terminal domain, containing from
four to six C2H2 type zinc fingers and bind to the E-box [37].
Snail expression was low in KYSE-510 cells, but was dramatically
increased after TGF-b1 treatment (Figure 4A), and RELN mRNA
expression was decreased in a time-dependent manner (Figure 4B).
Thereby, an inverse correlation between RELN mRNA and Snail
protein levels is observed upon TGF-b1 treatment. Interestingly,
there are 2 E-box sequences in RELN promoter region, and we
identified the recruitment of transcriptional repressor Snail to the
RELN promoter after TGF-b1 treatment. And the E-box located
from 2466 to 2460 bp (59-CAGCTG-39) was also identified as a
cyclic AMP responsive element binding protein (CREB) binding
site which has not been functionally characterized at this point
[38]. The mechanism study showed that Snail elevated responding
to the TGF-b1 treatment, then anchored to the E-box of RELN
promoter, and finally obstructed the expression of RELN. In
addition, we observed elevated expression of RELN mRNA after
treatment with the histone deacetylase inhibitor, TSA, in ESCC
cells (data not shown), and Snail was also reported to be interacted
with HDAC1 to repress E-cadherin expression [39,40]. And
RELN promoter was epigenetically regulated through DNA
methylation [21]. Equally important in this context is the interplay
between methylation, chromatin structure and histone deacetyla-
tion. Thus, we speculated that Snail might interact with various
Figure 2. TGF-b1 suppressed RELN expression and transient transfection of Reelin blocked TGF-b1-induced cell migration. A: RT-PCR
analysis showing RELN mRNA expression in eight ESCC cell lines, GAPDH was used as an internal control. B: Reelin protein was localized in cytoplasm
in KYSE-510 cells by immunostaining. Mouse IgG was used as isotype negative control. Scale bar:2 0mm. C: KYSE-510 cells were treated with 5 ng/ml
TGF-b1, RELN mRNA expression was examined by RT-PCR, and GAPDH was used as an internal control. D: Western blot for Reelin protein using whole
cell extract at 48 hours after reelin (pCrl) transfection in KYSE-30 cells. b-actin served as the loading control. E: 5 ng/ml TGF-b1 was added in media for
24 hours after pCrl transfection and Transwell assay was performed at 48 hours after transfection (left). The bar graph shows the relative number of
migrated cells from three independent experiments (right). Data represent the mean 6 SD of triplicate experiments. *, p,0.05.
doi:10.1371/journal.pone.0031802.g002
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RELN transcription and perhaps induce histone deacetylation in
ESCC cells.
Recently, several groups reported that loss of functional Reelin
was implicated in motility and invasion of pancreatic, gastric, and
breast cancer [5,6,7]. Our previous study showed that Reelin was
dysregulated in ESCC samples [41]. In this study, knockdown of
Reelin expression considerably enhanced mobility of ESCC cells,
which is consistent with previous reports [5]. Unfortunately,
further examination on ESCC specimens failed to find a
significant correlation between RELN expression and clinical
metastasis status. One possible explanation is that there are limited
amount of metastatic cancer cells in the tested specimens. Another
reason rests on multiple steps of metastasis. Because metastasis
consists of a serial of procedures and we have not determined in
which steps RELN may be involved. Therefore, the result in
ESCC tissues is not necessarily in conflict with the finding that
RELN suppressed cell migration of human ESCC cells.
In summary, Reelin is involved in TGF-b1-mediated cell
migration in ESCC cells, and the TGF-b1-induced migration
could be suppressed by Reelin expression. We further demon-
strated that Snail can regulate Reelin expression through binding
to Reelin promoter region in vivo after TGF-b1 treatment and
decreased RELN promoter activity in a dose-dependent manner.
And we showed that knockdown of Reelin induced the expression
of mesenchymal markers and increased cell migration in
KYSE510 cells. Our results provide the first evidence linking
Reelin to TGF-b signal pathway, which contribute to cancer
metastasis, and it is helpful for anti-cancer strategies.
Materials and Methods
Ethics Statement and Tissue Specimens
This study was approved by the ethical committees of the
Chinese Academy of Medical Sciences Cancer Institute and the
First Affiliated Hospital of Anhui Medical University, and
informed consent was obtained from each patient. Forty primary
human ESCC tissue specimens were provided by the First
Affiliated Hospital of Anhui Medical University (Anhui Province,
China). All the tissues were obtained at the time of surgery and
immediately stored in liquid nitrogen until use. None of the
patients had received radiotherapy or chemotherapy before
surgery. Patients diagnosed with metastasis had lymph node
metastasis verified by pathological analysis. For all the samples,
clinicopathologic characteristics (age, gender, differentiation,
stage, tumor depth, and lymph node metastasis) are shown in
Table 1 [42].
Cell Lines-Growth and Treatment
Human ESCC cell lines KYSE-30, KYSE-140, KYSE-150,
KYSE-180, KYSE-410, KYSE-450, KYSE-510, and EC9706
were all established from human ESCC patients. Among them, the
KYSE series were generous gifts from Dr. Y. Shimada at Hyogo
College of Medicine (Hyogo, Japan) and EC9706 was established
and maintained in our laboratory [43,44,45]. Cells were
maintained in RPMI-1640 supplemented with 10% fetal bovine
serum and antibiotics. Subconfluent cells were treated with 5 ng/
ml TGF-b1 (R&D system, Radnor, USA).
RNA Interference and Transfection
Small interfering RNAs (siRNA; Qiagen, Mississauga, Canada)
targeting the RELN (Hs_RELN_2_HP siRNA, AGGAACGC-
TTTGACAGTGAA; Hs_RELN_5_HP siRNA, ATGGGCG-
GCGTCAGCTAATTA) and the control small interfering RNA
scramble siRNA (AATTCTCCGAACGTGTCACGT) were used
at 25 nmol/L. Stable silencing of RELN was achieved using the
short hairpin RNA-based vector pGCsi-U6/neo/GFP (Gene-
chem, Shanghai, China) with the target sequence (AAG-
GAACGCTTTGACAGT-GAA or ATGGGCGGCGTCAGC-
TAATTA) and the negative control sequence (TTCTCC-
GAACGTGTCACGT). Hiperfect (Qiagen) was used for siRNA
transfection according to the manufacture’s protocols.
Plasmid Construction and Transfection
The Snail-HA expression vector which expresses Snail under
control of a pcDEF backbone was cloned in our lab, and the reelin
Figure 3. TGF-b1 treatment decreased RELN transcriptional activity, but did not affect RELN mRNA stability. A: TGF-b1 down-regulated
the RELN promoter activity. KYSE-510 cells were transiently transfected with pGL3-basic and the RELN promoter-luciferase construct, and
simultaneously treated by 5 ng/ml TGF-b1 at 24 hours after transfection. Data represent the mean 6 SD of triplicate experiments. *, p,0.05. B. KYSE-
510 cells were treated with or without 5 ng/ml TGF-b1 for 1 hour followed by actinomycin D (Act D;5mg/ml) treatment for the indicated time. RELN
mRNA level was measured by RT-qPCR (left) and plotted on a logarithmic scale to calculate the time required for each mRNA to reach one-half of its
initial abundance (right). Dotted line represents RELN mRNA expression after TGF-b1 treatment and straight line represents RELN mRNA expression of
untreated control.
doi:10.1371/journal.pone.0031802.g003
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Children’s Hospital of Philadelphia, Philadelphia, PA, USA) which
expresses full-length reelin under control of a cytomegalovirus
promoter in a pcDNA3 backbone (neomycin-resistant) was first
cloned by D’Arcangelo et al [46]. Lipofectamine 2000 (Invitrogen,
Carlsbad, USA) was used for plasmid transfection.
Production of Stable Cell Lines
KYSE-510 cells were plated on 60-mm dishes, cultured for
24 hours at 37uC, then transfected with 3 mg of negative shRNA
or RELN shRNA expression vector. Cells were reseeded on three
100-mm dishes at 24 hours after transfection, and cultured in 10%
fetal bovine serum of RPMI-1640 with 400 mg/ml G418. After a
2-week selection, the cell colonies were picked into 24-well plates
for stable cell lines setup, cultured in 10% fetal bovine serum of
RPMI-1640 with 200 mg/ml G418, and then screened with RT-
PCR.
Transwell Assay
For migration assay, KYSE-30 or KYSE-510 cells trypsinized
and seeded in medium without serum; then 1610
5 cells plated into
the upper chambers of cell culture inserts (24-well type, 8-mm pore
size, Corning, NY, USA), which were placed in medium
containing 20% fetal bovine serum served as chemoattractant.
After 24 or 30 hours of incubation, cells attached to the upper side
of the filter were mechanically removed, and cells that had
migrated to the undersurface of the membrane were fixed and
stained with crystal violet. Digital images were obtained from the
membranes, and three random fields were counted. The results
were averaged in three independent experiments. Transwell assays
were also performed after 5 ng/ml TGF-b1 treatment.
Immuofluorescence Analysis
Cells on chamber slides were fixed with 4% paraformaldehyde
for 30 min at room temperature and permeablized with 0.2%
Figure 4. Snail regulates RELN expression in ESCC cells. A&B: Snail protein was increased (A) and RELN mRNA was decreased (B) in a time-
dependent manner after 5 ng/ml TGF-b1 treatment in KYSE-510 cells. b-actin served as the loading control in Western blot. C: RT-qPCR analysis
showing that Snail down-regulates RELN mRNA expression in KYSE30 and KYSE-510 cells. Data represent the mean 6 SD of triplicate experiments. *,
p,0.05. D: Snail down-regulates RELN promoter activity in KYSE-30 and KYSE510 cells in a dose-dependent manner. Data represent the mean 6 SD
of triplicate experiments. E: Snail binds to the RELN promoter after TGF-b1 treatment in KYSE-510 cells. Schematic representation of RELN promoter
region, +1=transcription start site (left). ChIP assay was carried out by using a rabbit anti-Snail antibody or the rabbit IgG as described in Materials
and Methods. The presence of sequences corresponding to RELN promoters and b-actin were analyzed, and b-actin served as the negative control
(right).
doi:10.1371/journal.pone.0031802.g004
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31802Figure 5. Role of Reelin in cell migration. A: RT-PCR analysis showing RELN mRNA level in RELN and scramble siRNAs transfected cells, and
GAPDH was used as an internal control. B: Transwell assay showing that RELN knockdown increased cell migration. Cells were stained with crystal
violet (left). The bar graph shows the relative number of migrated cells from three independent experiments (mean+SE, right). *, p,0.05. C: RT-PCR
analysis showing RELN mRNA level in RELN shRNA and scramble clones. D: Transwell assay showing cell migration of the RELN shRNA and scramble
clones. Cells were stained with crystal violet (top). The bar graph shows the relative number of migrated cells from three independent experiments
(mean+SE, bottom). *, p,0.05. E: RT-qPCR showing the mRNA expression of some EMT markers in RELN shRNA and scramble clones. Data represent
the mean 6 SD of triplicate experiments.
doi:10.1371/journal.pone.0031802.g005
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with Reelin antibody (Santa Cruz) in PBS at 4uC overnight
followed 3 washes in PBS and subsequent incubation with
appropriate fluorescent secondary antibody conjugates for
30 minutes. Images were collected using Leica Confocal Laser
Scanning microscopy (Leica Microsystems, Wetzlar, Germany).
RNA Isolation and PCR Analysis
Total RNA was isolated by using Trizol reagent (Invitrogen)
according to the manufacturer’s instructions. Conventional reverse
transcription-PCR (RT-PCR) and quantitative RT-PCR (RT-
qPCR) were carried out using PrimeScript One-Step RT-PCR kit
and One-Step SYBR PrimeScript RT-PCR kit (TaKaRa, Dalian,
China) respectively. The primers used include: RELN, forward 59-
TGCTGCAATACAGCGTCAACAA-39 and reverse 59-CGAC-
CTCCACATGGTCCAAAG-39; Vimentin, forward 59-GA-
GAAC-TTTGCCGTTGAAGC-39 and reverse 59-GCTTCCT-
GTAGGTGGCAATC-39; Fibronectin, forward 59-CAGTGG-
GAGACCTCGAGAAG-39 and reverse 59- TCCCTC-GGAA-
CATCAGAAAC-39; N-cadherin, forward 59- ACAGTGGC-
CACCTACAAAG-G-39 and reverse 59-CCGAGATGGGGT-
TGATAATG-39; E-cadherin, forward 59-TGCCCAGAAAAT-
GAAAAAGG -39 and reverse 59- GTGTATGTGGCAATG-
CGT-TC-39; GAPDH, forward 59-ACCACAGTCCATGCCAT-
CAC-39 and reverse 59-TCCACCACCCTGTTGCTGTA-39.
Actinomycin D (ActD; Sigma, St. Louis, USA) was used to inhibit
RNA synthesis in KYSE-510 cells. The expression of each gene
relative to GAPDH was calculated using a modified method of
delta Ct (2
2DCt) described by Lehmann and Kreipe [47].
Chromatin Immunoprecipitation
Chromatin immunoprecipitation analysis (ChIP) was performed
with Chromatin Immunoprecipitation Assay Kit (Millipore, Bill-
erica, USA) using rabbit anti-Snail (Santa Cruz biotechnology,
Santa Cruz, USA) or control rabbit IgG (Zhongshanjinqiao,
Beijing, China) according to the manufacturer’s instructions. The
primers used include: RELN, forward 59-AAAAACAGGGCA-
CACTGACG -39 and reverse 59-TCCACACCT-TCTTAAAG-
CCCC-39; b-actin, forward 59-GTTCTGCTCCGGGAATCA-
CAG-39 and reverse 59- ACGCGCTGCAAAGAGCCCCGC-39.
Luciferase Reporter Gene Assay
The minimal promoter region of RELN [21] was constructed.
Cells were plated on 96-well plates, grown to a density of 30,50%
and transfected with the RELN promoter construct or empty
vector (pGL3-Basic) using Lipofectamine 2000. Forty-eight hours
after transfection, luciferase activity was measured in triplicate
using the Dual- Luciferase Assay System (Promega, Madison,
USA) and normalized for Renilla luciferase activity in correspond-
ing samples. Luciferase reporter gene assays were also performed
in the presence of 5 ng/ml TGF-b1.
Western Blot
Cell lysates were size-fractionated by SDS-PAGE and trans-
ferred onto polyvinylidene difluoride membrane. Protein bands
were detected by chemiluminescence using the ECL system
(Vigorous Biotech, Beijing, China) according to the manufacture’s
protocol. Mouse anti-N-cadherin (R&D), rabbit anti-E-cadherin
(Santa Cruz), rabbit anti-Snail (Santa Cruz), mouse anti-Reelin
(G10) (Millipore), and mouse anti-b-actin (Sigma) were used.
Statistics
Some data are shown as means 6 SD from the number of
independent experiments as indicated. Statistical analysis was
performed using Student’s t test. All statistical analyses were
performed using SPSS software. Differences were considered
significant at P,0.05.
Supporting Information
Figure S1 TGF-b1 induced cell morphologic changes
and suppressed RELN expression in KYSE-30 cells. Cells
Figure 6. RT-qPCR analysis showing the relative expression of
RELN mRNA in 40 human ESCC tissues. The term 2DCt was used
to describe the relative expression level of RELN (2DCt=CtGAPDH-
CtRELN). No significant difference was detected in the mean value of
RELN expression between these two groups (p=0.3803).
doi:10.1371/journal.pone.0031802.g006
Table 1. The clinicopathologic characteristics of 40 ESCC
patients.
Clinicopathologic characteristics Case numbers
Age (median) 38–72 (57)
Sex (male/female) 30/10
Differentiation (well/moderate/poor) 14/17/9
Stage (I/II/III/IV) 1/18/20/1
Tumor depth (submucosa/muscularis propria/adventitia) 4/9/27
Lymph node metastasis (negative/positive) 20/20
doi:10.1371/journal.pone.0031802.t001
Table 2. Relationship between RELN mRNA expression level
and clinicopathological features in 40 primary ESCC samples.
Features
Case
numbers
RELN expression
(2DCt) P-value
Stage(TNM)
Stage I/II 19 212.2 0.146
Stage III/IV 21 213.5
Lymph node metastasis
negative 20 213.2 0.3803
positive 20 212.6
RELN expression means mRNA expression in human ESCC tissues described in
Figure 6.
Student’s t test was used to examine the difference of RELN mRNA levels.
doi:10.1371/journal.pone.0031802.t002
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treatment of TGF-b1 or control, morphologic phenotypes and
KYSE-30 cells were examined under an inverted phase-contrast
microscope. Scale bars, 20 mm. B: MTT assay showing the cell
viability and proliferation of KYSE-30 after TGF-b1 treatment. C:
RT-qPCR analysis showing the mRNA expression levels of
Vimentin in KYSE-30 cells with or without TGF-b1 treatment
for indicated time. Data represent the mean 6 SD of triplicate
experiments. D: RELN mRNA expression was examined by RT-
qPCR, and GAPDH was used as an internal control.
(TIF)
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